JP2019531100A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019531100A5 JP2019531100A5 JP2019542759A JP2019542759A JP2019531100A5 JP 2019531100 A5 JP2019531100 A5 JP 2019531100A5 JP 2019542759 A JP2019542759 A JP 2019542759A JP 2019542759 A JP2019542759 A JP 2019542759A JP 2019531100 A5 JP2019531100 A5 JP 2019531100A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- construct
- sequences shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 93
- 108090000765 processed proteins & peptides Proteins 0.000 claims 93
- 102000004196 processed proteins & peptides Human genes 0.000 claims 93
- 150000001413 amino acids Chemical class 0.000 claims 35
- 230000002163 immunogen Effects 0.000 claims 19
- 229940024606 amino acid Drugs 0.000 claims 18
- 235000001014 amino acid Nutrition 0.000 claims 18
- 108090000623 proteins and genes Proteins 0.000 claims 16
- 241000191967 Staphylococcus aureus Species 0.000 claims 13
- 239000012634 fragment Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 9
- 102000039446 nucleic acids Human genes 0.000 claims 9
- 150000007523 nucleic acids Chemical class 0.000 claims 9
- 239000013598 vector Substances 0.000 claims 9
- 241000124008 Mammalia Species 0.000 claims 8
- 230000002238 attenuated effect Effects 0.000 claims 7
- 101100227953 Staphylococcus aureus (strain COL) fur gene Proteins 0.000 claims 6
- 241000191940 Staphylococcus Species 0.000 claims 5
- 101100404789 Staphylococcus aureus (strain COL) nikC gene Proteins 0.000 claims 5
- 101100422138 Staphylococcus aureus (strain COL) splC gene Proteins 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 101100211536 Staphylococcus aureus (strain COL) SACOL2365 gene Proteins 0.000 claims 2
- -1 cell Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 206010041925 Staphylococcal infections Diseases 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 229940037003 alum Drugs 0.000 claims 1
- 229940009098 aspartate Drugs 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- USSYUMHVHQSYNA-SLDJZXPVSA-N indolicidin Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)CC1=CNC2=CC=CC=C12 USSYUMHVHQSYNA-SLDJZXPVSA-N 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 229920002627 poly(phosphazenes) Polymers 0.000 claims 1
- 229920002704 polyhistidine Polymers 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022183528A JP2023025066A (ja) | 2016-10-21 | 2022-11-16 | ワクチン構築物およびブドウ球菌感染症に対するその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662411120P | 2016-10-21 | 2016-10-21 | |
| US62/411,120 | 2016-10-21 | ||
| PCT/CA2017/051253 WO2018072031A1 (en) | 2016-10-21 | 2017-10-20 | Vaccine constructs and uses thereof against staphylococcus infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022183528A Division JP2023025066A (ja) | 2016-10-21 | 2022-11-16 | ワクチン構築物およびブドウ球菌感染症に対するその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019531100A JP2019531100A (ja) | 2019-10-31 |
| JP2019531100A5 true JP2019531100A5 (OSRAM) | 2020-11-26 |
| JP7181208B2 JP7181208B2 (ja) | 2022-11-30 |
Family
ID=62018642
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019542759A Active JP7181208B2 (ja) | 2016-10-21 | 2017-10-20 | ワクチン構築物およびブドウ球菌感染症に対するその使用 |
| JP2022183528A Withdrawn JP2023025066A (ja) | 2016-10-21 | 2022-11-16 | ワクチン構築物およびブドウ球菌感染症に対するその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022183528A Withdrawn JP2023025066A (ja) | 2016-10-21 | 2022-11-16 | ワクチン構築物およびブドウ球菌感染症に対するその使用 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US11324815B2 (OSRAM) |
| EP (1) | EP3529260A4 (OSRAM) |
| JP (2) | JP7181208B2 (OSRAM) |
| KR (1) | KR20190082229A (OSRAM) |
| CN (1) | CN109843910A (OSRAM) |
| AR (1) | AR109847A1 (OSRAM) |
| AU (2) | AU2017346974B2 (OSRAM) |
| BR (1) | BR112019007796A2 (OSRAM) |
| CA (1) | CA3037070A1 (OSRAM) |
| CL (1) | CL2019001048A1 (OSRAM) |
| CO (1) | CO2019005169A2 (OSRAM) |
| CR (1) | CR20190249A (OSRAM) |
| DO (1) | DOP2019000102A (OSRAM) |
| IL (1) | IL265869A (OSRAM) |
| MX (2) | MX2019004539A (OSRAM) |
| MY (1) | MY195369A (OSRAM) |
| NZ (1) | NZ751880A (OSRAM) |
| PE (1) | PE20191320A1 (OSRAM) |
| PH (1) | PH12019500843A1 (OSRAM) |
| RU (2) | RU2022100889A (OSRAM) |
| SG (2) | SG10201912431XA (OSRAM) |
| TW (1) | TW201819402A (OSRAM) |
| UY (1) | UY37448A (OSRAM) |
| WO (1) | WO2018072031A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113777317A (zh) * | 2020-06-09 | 2021-12-10 | 首都医科大学附属北京世纪坛医院 | 尿液主穹隆蛋白及其多肽片段在烧伤中的应用 |
| US20220185852A1 (en) * | 2020-12-11 | 2022-06-16 | Bayer Animal Health Gmbh | Methods and compositions for improved production of an antigen for use in an s. aureus vaccine |
| WO2026014994A1 (ko) * | 2024-07-12 | 2026-01-15 | 주식회사 더윤헬스텍 | 젖소 유방염 유래 대장균 또는 황색 포도알균 변이주 및 이를 포함하는 백신 조성물 |
| US12161970B1 (en) | 2024-08-09 | 2024-12-10 | Jiaxing Research Institute, Zhejiang University | CO2 desorption system suitable for limited space in complex sailing region and flexible control method |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1288774C (en) | 1985-01-07 | 1991-09-10 | Deborah A. Eppstein | 1,2-dialkoxy-w-trialkylammonium cationic surfactants |
| US6228844B1 (en) | 1991-11-12 | 2001-05-08 | Vical Incorporated | Stimulating vascular growth by administration of DNA sequences encoding VEGF |
| US7060458B1 (en) | 1997-08-14 | 2006-06-13 | Wyeth | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| US6833134B2 (en) | 2000-06-12 | 2004-12-21 | University Of Saskacthewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
| GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| MXPA05005045A (es) | 2002-11-12 | 2005-07-01 | Brigham & Womens Hospital | Vacuna de polisacarido para infecciones estafilococicas. |
| CN1569893A (zh) | 2003-07-21 | 2005-01-26 | 中国人民解放军军事医学科学院基础医学研究所 | 金葡菌毒力因子调控蛋白的抗原表位及其模拟表位和用途 |
| RU2419628C2 (ru) | 2004-09-22 | 2011-05-27 | ГлаксоСмитКлайн Байолоджикалз с.а. | Иммуногенная композиция для применения в вакцинации против стафилококков |
| BRPI0516974A (pt) * | 2004-10-21 | 2008-09-30 | Wyeth Corp | composição imunogênica compreendendo um polipeptìdeo; um método para induzir uma resposta imune contra staphylococcus epidermidis; um método para induzir uma resposta imune contra staphylococcus aureus; um método para a detecção e/ou identificação de staphylococcus epidermidis; um método para a detecção e/ou identificação de anticorpos para staphylococcus epidermidis |
| KR100729954B1 (ko) | 2004-12-01 | 2007-06-20 | 주식회사 엘지생명과학 | Ｓｅｃ１ 변이 단백질의 제형 및 그것의 제형화 방법 |
| CA2667788A1 (en) | 2006-10-30 | 2008-12-18 | The University Of Western Ontario | Staphylococcus aureus specific anti-infectives |
| EP2411046B1 (en) | 2009-03-23 | 2017-12-06 | Epitopix, LLC | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| NZ612315A (en) | 2009-04-14 | 2014-10-31 | Novartis Ag | Compositions for immunising against staphylococcus aureus |
| CA2792956C (en) * | 2010-03-17 | 2021-11-16 | Socpra - Sciences Et Genie, S.E.C. | Bacterial vaccine components from staphylococcus aureus and uses thereof |
| BR112013032774B1 (pt) | 2011-06-19 | 2020-05-05 | Univ New York | composições compreendendo proteína luke isolada ou polipeptídeo da mesma, uma proteína lukd isolada ou polipeptídeo da mesma ou sua combinação, bem como seu uso |
-
2017
- 2017-10-20 BR BR112019007796A patent/BR112019007796A2/pt not_active IP Right Cessation
- 2017-10-20 JP JP2019542759A patent/JP7181208B2/ja active Active
- 2017-10-20 US US16/337,457 patent/US11324815B2/en active Active
- 2017-10-20 RU RU2022100889A patent/RU2022100889A/ru unknown
- 2017-10-20 MY MYPI2019002159A patent/MY195369A/en unknown
- 2017-10-20 TW TW106136089A patent/TW201819402A/zh unknown
- 2017-10-20 CA CA3037070A patent/CA3037070A1/en active Pending
- 2017-10-20 PE PE2019000844A patent/PE20191320A1/es unknown
- 2017-10-20 AU AU2017346974A patent/AU2017346974B2/en not_active Ceased
- 2017-10-20 RU RU2019115303A patent/RU2766354C2/ru active
- 2017-10-20 CR CR20190249A patent/CR20190249A/es unknown
- 2017-10-20 WO PCT/CA2017/051253 patent/WO2018072031A1/en not_active Ceased
- 2017-10-20 SG SG10201912431XA patent/SG10201912431XA/en unknown
- 2017-10-20 CN CN201780064991.1A patent/CN109843910A/zh active Pending
- 2017-10-20 NZ NZ751880A patent/NZ751880A/en unknown
- 2017-10-20 AR ARP170102922A patent/AR109847A1/es not_active Application Discontinuation
- 2017-10-20 SG SG11201901483QA patent/SG11201901483QA/en unknown
- 2017-10-20 KR KR1020197014191A patent/KR20190082229A/ko not_active Abandoned
- 2017-10-20 UY UY0001037448A patent/UY37448A/es unknown
- 2017-10-20 EP EP17863203.0A patent/EP3529260A4/en active Pending
- 2017-10-20 MX MX2019004539A patent/MX2019004539A/es unknown
-
2019
- 2019-04-07 IL IL265869A patent/IL265869A/en unknown
- 2019-04-16 PH PH12019500843A patent/PH12019500843A1/en unknown
- 2019-04-17 MX MX2023001219A patent/MX2023001219A/es unknown
- 2019-04-17 DO DO2019000102A patent/DOP2019000102A/es unknown
- 2019-04-17 CL CL2019001048A patent/CL2019001048A1/es unknown
- 2019-05-21 CO CONC2019/0005169A patent/CO2019005169A2/es unknown
-
2022
- 2022-04-05 US US17/713,683 patent/US20220288183A1/en not_active Abandoned
- 2022-06-28 AU AU2022204585A patent/AU2022204585A1/en not_active Abandoned
- 2022-11-16 JP JP2022183528A patent/JP2023025066A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2280721T1 (en) | Indoleamine 2, 3-dioxygenase based immunotherapy | |
| SI2707393T1 (en) | Fusion proteins and combined vaccines comprising protein E and AH haemophilus influenzae | |
| JP2008538183A5 (OSRAM) | ||
| JP2008525033A5 (OSRAM) | ||
| JP2015522576A5 (OSRAM) | ||
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| RU2007139915A (ru) | Haemophilus influenzae типа в | |
| IL276210B2 (en) | Mers-cov vaccine | |
| JP2014507146A5 (OSRAM) | ||
| JP2015500827A5 (OSRAM) | ||
| JP2021519597A5 (OSRAM) | ||
| JP2012115277A5 (OSRAM) | ||
| JP2015514132A5 (OSRAM) | ||
| CA2380833A1 (en) | Proteins derived from white spot syndrome virus and uses thereof | |
| JP2013520487A5 (OSRAM) | ||
| JP2013523718A5 (OSRAM) | ||
| JP2024508683A5 (OSRAM) | ||
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| RU2022100889A (ru) | Вакцинные конструкты и их применения против инфекций стафилококка | |
| CN104844712A (zh) | 肺炎链球菌蛋白抗原及其制备方法和应用 | |
| JP2017513849A5 (OSRAM) | ||
| JP2023522154A5 (OSRAM) | ||
| JP2019526261A5 (OSRAM) | ||
| TW201808985A (zh) | 衍生自精胺酸密集區之經修飾抗菌胜肽 | |
| JP2009527510A5 (OSRAM) |